MedTrace Logo

Intraoperative Subanesthetic Ketamine Versus Dexmedetomidine Infusion for Prevention of Post-traumatic Stress Disorder After Traumatic Brain Surgeries

NCT06498700 · Status: ENROLLING_BY_INVITATION · Phase: NA · Type: INTERVENTIONAL · Enrollment: 52

Last updated 2024-08-19

No results posted yet for this study

Summary

Prevention of Post-traumatic Stress Disorder after traumatic Brain surgeries by using either subanesthetic ketamine or dexmedetomidine infusion.

Conditions

  • Subanesthetic Ketamine Dexmedetomidin

Interventions

DRUG

ketamine

0.5 mg/kg/h ketamine infusion

DRUG

dexmedetomidine

0.1 ug/kg/h dexmedetomidine infusion

Sponsors & Collaborators

  • Zagazig University

    lead OTHER_GOV

Principal Investigators

  • marwa M Medhat · Zagazig University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-07-15
Primary Completion
2024-12-15
Completion
2025-03-15

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06498700 on ClinicalTrials.gov